At this visit the PN will lead the discussion with the patient around general diabetes management and education and train patients to administer a single injection of insulin glargine with the Solostar™ injecting device.
During injection the syringe is placed in specially designed gun-like injecting device, with ability to inject same amount of Urolastic at each trigger pushing.
Here we report the development of a dual-signal flow injected analysis device which eliminates the need for sample pretreatment.
The same type of disposable injecting device (Solostar™, Sanofi) will be used for both insulin glargine and glulisine.
The micro-bypass iStent inject device GTS400 is a single-piece, heparin-coated, gamma-sterilized device made from implant-grade titanium.
A similar disposable injecting device (Solostar™, Sanofi) mechanism used for both glargine and glulisine minimizes need for further education of primary care physicians, PNs and patients.
This report summarizes data from patients who underwent implantation of the second generation GTS-400 inject inject device via either the Model G2-0 injector or the Model G2-M-IS Injector as a sole procedure.
To visually demonstrate the ability to introduce solutions containing chemicals and pharmacologically active compounds into this device, red and blue dyes were sequentially injected into the device.
The iStent inject devices are pre-loaded in the customized injector system designed to deliver the stents automatically into Schlemm's canal through a stainless steel insertion tube.
